Lupin Limited (BSE: 500257, NSE: LUPIN) received U.S. Food and Drug Administration approval for its risperidone extended-release injectable suspension in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE